In a message dated 5/16/2003 8:43:05 AM Eastern Daylight Time,
[log in to unmask] writes:

>
> Date:   Fri, 16 May 2003 07:48:52 -0400
> From:   "Nice, Frank (NIH/NINDS)" <[log in to unmask]>
> Subject: Trifluridine 1% (Viroptic)---WOW!--Check what the drug company sa
> ys
> MIME-Version: 1.0
> Content-Type: text/plain; charset="ISO-8859-1"
>
> This is a case, believe it or not, where the drug company's product
> information supports breastfeeding--yet both the pharmacist and the doctor
> missed it:
>
> After ophthalmic instillation, trifluridine excretion in human breast milk
> is unlikely due to the relatively small dose administered, the dilution in
> body fluids, and the very short half-life (Product Information Viroptic
> (R),
> 1998).
>
> Whenever one is dealing with ophthalmics and breastfeeding, in MOST cases,
> the above is true, and MOST ophthalmics can be used while breastfeeding.
>
> Frank J. Nice, DPA, CPHP
>
>        ***********************************************
>
> To temporarily stop your subscription: set lactnet nomail
> To start it again: set lactnet mail (or digest)
> To unsubscribe


             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html